Market Dynamics
Rising adoption of minimally
invasive surgical procedures is expected to fuel growth of the Neuro-Navigation
Systems Market. Moreover, increasing number of neurological surgeries
performed worldwide is also expected to drive demand for neuro-navigation
market. According to the AANS National Neurosurgical Procedural Statistics, in
2011, neurosurgeons performed 2,296,331 total procedures, 1,448,400 of which
were spine surgeries in the U.S. Rise in number of people suffering with brain
tumor and cancer leading to brain metastasis is expected to propel demand for
neuro-navigation systems. According to American Brain Tumor Association, over
688,000 people in the U.S. lived with primary brain or central nervous system
(CNS) tumor. The data also suggests that around 20-40% of other cancer later
develops into brain metastasis. Various technical advancements in
neuro-navigation system such as addition of features, higher success rate, and
newer application of the device depending on its usage in various surgical
procedures indicates shift of neurosurgeons on using these systems more
frequently for performing neuro-surgical procedures. Moreover, ease of
operation, improved quality of treatment, and improved surgical results is also
expected to increase demand for neuro-navigation systems. Additionally,
advantages such as reduced hospital stay and improved accuracy in
neuro-surgeries are expected to be driving factors for growth of the global
neuro-navigation systems market size. However, high costs associated with these
systems and lack of skilled workforce to operate these systems are expected to
restrain growth of the global market.
Neuro-navigation also known to as
frameless stereotactic surgery refers to the technique that involves
performance of real-time intraoperative guidance during spinal or brain
injuries. Neuro-navigation increases safety and accuracy during neurosurgery.
Neuro-navigation systems help to guide the surgeon to the surgical targets
without the need for external frames. These systems are majorly used in brain
surgeries that helps to limit the size of skull opening or craniotomy and
remove brain lesions such as tumors or other tissue masses. Neuro-navigation
systems are primarily used for tumor resection in frameless stereotactic
procedure that relies on fiducial markers on the brain that are taped on the
scalp before imaging. These systems are also utilized while performing brain
biopsies in case of deep brain tumors, wherein the surgical tumor removal
through open brain surgery is difficult and life threatening. The most
important function of neuro-navigation system is to develop a precise replica
of the patient’s brain tumor, which can be done through a number of imaging
technology such as X-rays, CT scans, MRIs, and ultra sound. Images obtained
from this techniques are then uploaded in the systems to form a 3 dimensional
data set that produces exact geometrical structure of the region to be
operated. The image is then analyzed to extract relevant information from the
data and by using specialized software and the dataset is rendered as a virtual
3D model of the patient brain structure assisting tumor location, which helps
the surgeon during the surgery and perform tumor removal.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1748
Key Developments in
Neuro-Navigation Systems
In June 2015, Centre Hospitalier
Sainte Anne initiated clinical trial study to investigate the therapeutic
efficacy of neuronavigated repetitive Transcranial Magnetic Stimulation (TMS)
of right angular gyrus in patients with depersonalization disorder. The study
is estimated to complete in September 2019.
In April 2017, Medtronic Plc.
launched StealthStation S8 neurosurgical intraoperative imaging and navigation
system. The StealthStation S8 includes upgraded software interface, a 2-cart
platform design and electromagnetic technology.
In July 2018, Xoran Technologies,
a developer of compact, point-of-care CT scanners, and Fiagon AG Medical
Technologies, a developer of electromagnetic surgical navigation systems, have
collaborated to strengthen their position in Neuro and Spine markets.
In May 2018, Nexstim, provider of
Navigated TMS, launched its Navigated Brain Therapy transcranial magnetic
stimulation system in the U.S. The device is designed to treat major depressive
disorder.
In May 2019, MagStim, a developer
of transcranial magnetic stimulation (TMS) technology, launched StimGuide TMS
navigation system. The device is designed to provide precise and consistent
coil positioning during treatments in depressive disorder.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/neuro-navigation-systems-market-1748
Regional Insights
In terms of geography
neuro-navigation systems market is segmented into North America, Europe, Asia
Pacific, Middle East, Latin America, and Africa. North America is dominant in
the neuro-navigation systems market, owing to increasing incidence of brain
tumors as well as rising health awareness in the region. According to the
American Cancer Society (ACS), brain and spinal cord tumors affects both adults
and children in the U.S. The ACS suggests that approximately 23,880 malignant
tumors for brain and spinal cord are expected to be diagnosed in the U.S. in
2018. On the other hand, Asia Pacific is expected to witness maximum traction
in the neuro-navigation market, owing to market players launching their
products in the Asian markets due to presence of huge potential user base. For
instance, in October 2017, Pearl Technology introduced a CT HeadFix
neuro-navigation system that offers a comfortable, integrated, fast, and
hygienic positioning solution in Asia Pacific and European region post its
approval from the U.S. FDA.
Competitive Landscape
The market for the
neuro-navigation systems is highly competitive with presence of various
established players, which includes Medtronic plc, Stryker Corporation, Siemens
Healthineers, Zimmer Biomet Holding Inc., Brainlab AG, B. Braun Melsungen AG,
Scopis GmBH, Amplitude Surgical, and others. Key players are focusing towards
introducing novel systems in the market to sustain their position. For
instance, in April 2017, Medtronic Plc introduced StealthStation S8 model, a
neuro-navigation system that enhanced workflows, efficiency, and provides
comprehensive data integration assisting the neurosurgeons during brain
surgery.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1748
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment